Your Cart is Empty
BUY 1 GET 1 FREE · AUTO APPLIES AT CHECKOUT
Medical Disclaimer | This article is for informational purposes only. Valerian root has additive CNS depressant effects with alcohol, benzodiazepines, and sedatives. Very high-dose valerian has been associated with rare hepatotoxicity — stay within standard doses (300–600mg). CBD and valerian are supplements. PureCraft CBD products are broad-spectrum zero-THC, batch-verified at purecraftcbd.com/pages/faq. Individual results may vary.
Valerian root (Valeriana officinalis) is one of the oldest medicinal herbs in Western use — recorded in ancient Greece and Rome for sleep and anxiety, and one of the top-selling herbal supplements globally. Its primary active compound, valerenic acid, inhibits GABA transaminase and acts as a positive allosteric modulator of GABA-A receptors — a mechanism that places it in the same pharmacological family as benzodiazepines and barbiturates, albeit far weaker.
The most important distinction between CBD and valerian issedation versus anxiety relief. Valerian works primarily by increasing GABA-A-mediated neuronal inhibition — producing mild sedation. CBD works primarily through 5-HT1A serotonin receptor activation and HPA recalibration — producing anxiety relief without sedation. These are fundamentally different outcomes: valerian helps you feel drowsy and sleep; CBD helps you feel calm and not anxious, with sleep following as a consequence. The distinction matters enormously for practical use: valerian is strictly a nighttime supplement;CBD Oil is appropriate anytime — morning, afternoon, or evening.
Valerenic acid (VA) — the primary bioactive sesquiterpene in valerian root — acts as apositive allosteric modulator of GABA-A receptors. It enhances the effect of GABA (gamma-aminobutyric acid) at GABA-A receptors without directly activating them — increasing the frequency of chloride ion channel opening when GABA is present, producing neuronal inhibition. This is the same mechanism as benzodiazepines (which are also GABA-A positive allosteric modulators) at a weaker potency.
The practical consequence: valerenic acid producesmild sedation and reduced arousal — helpful for sleep onset in people whose primary problem is difficulty 'shutting off.' It also providesanxiolytic effects — but the mechanism produces sedation alongside anxiety relief, unlike CBD's 5-HT1A mechanism which produces anxiety relief without sedation. At nighttime doses (300–600mg), valerian produces noticeable drowsiness. At higher doses, next-day grogginess is the most common reported side effect.
Valerian also inhibits adenosine reuptake — increasing synaptic adenosine, the endogenous sleep-promoting nucleoside that caffeine blocks. This adenosine mechanism contributes to valerian's sleep-promoting effects independently of the GABA-A pathway.
The GABA-A mechanism is where valerian's most important safety and interaction considerations arise. While valerian is far weaker than pharmaceutical benzodiazepines (diazepam, lorazepam), the shared GABA-A mechanism means:
CBD at standard doses does not share these concerns — 5-HT1A partial agonism does not produce GABA-A-adjacent dependence risk, does not potentiate alcohol sedation, and does not interact additively with benzodiazepines.
CBD Oil provides several mechanisms that valerian cannot replicate:
Where valerian provides mechanisms thatCBD Oil cannot replicate:
The Cochrane reviews and systematic analyses of valerian for sleep disorders produce a consistent conclusion:evidence is inconclusive. Individual RCTs show positive results; pooled analyses show inconsistent effects that do not reach statistical significance across studies. The heterogeneity in valerian preparations (different species, different extraction methods, variable valerenic acid content) contributes to the inconsistency. The most consistent finding: valerian reduces subjective sleep latency and improves subjective sleep quality in some people — but the objective sleep architecture data is not as consistent as the subjective reports.
The dose range with most evidence: 300–600mg standardized valerian root extract, taken 30–60 minutes before bed. Lower doses (100–200mg) show weaker effects; higher doses (>600mg) increase grogginess without improved efficacy.
CBD Oil's sleep evidence is mechanistically strong (HPA recalibration, 5-HT1A anxiety reduction, CBN slow-wave architecture all have documented relevant mechanisms) but RCT evidence for sleep specifically at supplement doses is moderate — Shannon et al. (2019) showed improved sleep scores in a large case series; mechanism-focused research supports the pathways but large sleep RCTs are limited. CBD's anxiety RCT evidence is stronger than valerian's — and for anxiety-driven insomnia, the anxiety mechanism is the most relevant. SeeCBD for Insomnia: Does It Actually Put You to Sleep? andCBD for Sleep: The Ultimate 2026 Guide to Better Rest.
CBD and valerian are compatible at standard doses with one important consideration:additive sedation. Both have mild CNS-calming/sleep-promoting effects through different mechanisms — valerian via GABA-A, CBD via 5-HT1A and CBN. The combination at standard doses (15–20mg CBD + 300–450mg valerian) is unlikely to produce problematic sedation in most healthy adults. At higher doses of both: additive sedation could produce excessive drowsiness.
The practical stacking guidance: if combining CBD and valerian, take both at the same time (30–45 minutes before bed) andstart with lower doses of each to assess the combined effect. Do not drive or operate machinery after taking high doses of valerian regardless of CBD use. Do not combine with alcohol, benzodiazepines, or other sedatives. The combination is most appropriate for people who have tried each independently and want to address both the GABA-A sedation dimension (valerian) and the HPA/architecture dimension (CBD+CBN). SeeCBD Supplement Stacking Guide: How to Combine CBD With Other Supplements Safely.
|
Category |
CBD (Oil + Sleep Gummies) |
Valerian Root |
|
Primary mechanism |
5-HT1A anxiolytic; HPA cortisol recalibration; CBN CB1 slow-wave architecture; FAAH/anandamide ECS tone |
Valerenic acid GABA-A positive allosteric modulation; adenosine reuptake inhibition; weak 5-HT5a receptor interaction; mechanism partially overlaps with benzodiazepines |
|
Sleep onset |
Moderate (indirect via anxiety/HPA reduction); cumulative over 2–4 weeks |
Moderate — GABA-A sedation reduces sleep latency; effect more immediate than CBD; requires 2–4 weeks for full benefit in some studies |
|
Sedation quality |
Non-sedating — CBD reduces anxiety without sedation; CBN has mild sedating properties in Sleep Gummies at physiological doses |
Sedating — valerenic acid GABA-A activity produces mild sedation; next-day grogginess possible at high doses; more pharmacologically sedating than CBD |
|
Sleep architecture |
CBN promotes NREM stage 3 slow-wave; HPA recalibration reduces 3AM cortisol awakening |
Some studies show improved NREM; mechanism less directly architecture-targeted than CBN; variable results across trials |
|
Anxiety reduction |
5-HT1A direct anxiolytic — the best non-pharmaceutical mechanism for acute and chronic anxiety |
GABA-A sedation reduces acute anxiety; not a direct 5-HT1A mechanism; more sedating than anxiolytic at typical doses |
|
Daytime use |
Oil appropriate daytime for anxiety/HPA; Sleep Gummies at night only |
Not appropriate for daytime use — GABA-A sedation impairs alertness; strictly a nighttime supplement |
|
Drug interactions |
CYP3A4 inhibitor (moderate); careful with CNS depressants at high CBD doses |
CYP3A4 substrate AND mild inhibitor; additive CNS depression with alcohol, benzodiazepines, sedatives — more interaction concern than CBD |
|
Dependence risk |
No dependence documented |
Low but higher than CBD — GABA-A mechanism shares pharmacological family with benzodiazepines; theoretical mild dependence/tolerance with chronic high-dose use |
|
Next-day grogginess |
None at standard doses |
Possible at higher doses; the most common reported side effect of valerian |
|
Evidence quality |
Anxiety: multiple positive RCTs; sleep: mixed but consistent mechanism; HPA: documented |
Sleep: mixed — Cochrane reviews show inconclusive evidence; anxiety: limited; overall evidence quality lower than CBD for anxiety |
|
Stack compatibility |
Compatible — different mechanisms; concern about additive sedation at high doses of both |
Compatible at low doses; watch additive sedation at high doses; the combination is not contraindicated but the sedation overlap requires dose awareness |
The comparison table's most important practical distinction:valerian is strictly nighttime; CBD is anytime. This single difference makesCBD Oil more versatile and more appropriate as the daily foundation supplement. Valerian, if used, is best as an occasional nighttime addition for acute sleep onset difficulty — not a daily chronic supplement given the GABA-A mechanism's interaction profile and theoretical tolerance concerns.CBD+CBN Sleep Gummies provides the optimal nightly combination of CBD + CBN + physiological melatonin — covering the architecture, circadian, and HPA dimensions without valerian's daytime impairment risk.
Depends on the sleep problem. Valerian is faster-acting for sleep onset through GABA-A sedation — useful for people whose primary problem is 'can't fall asleep' with acute difficulty shutting off.CBD Oil +CBD+CBN Sleep Gummies is better for: anxiety-driven insomnia (5-HT1A mechanism), non-restorative sleep (CBN slow-wave), 3AM awakening (HPA recalibration), and daytime anxiety. For pure acute sleep onset difficulty in a healthy adult with normal architecture: valerian may produce more immediately noticeable sleep onset. For comprehensive insomnia with anxiety, architecture, and HPA components:CBD+CBN Sleep Gummies is more mechanistically complete.
Yes, at standard doses — 15–20mg CBD + 300–450mg valerian, taken together 30–45 min before bed. The combination provides complementary mechanisms (GABA-A sedation + 5-HT1A + CBN architecture) that together address more sleep dimensions than either alone. Start with lower doses of each to assess additive sedation. Do not combine with alcohol or benzodiazepines. Not appropriate for daytime use. SeeCBD and Drug Interactions: The Complete CYP450 Guide.
No — CBD's 5-HT1A anxiolytic mechanism is more directly evidence-supported for anxiety than valerian's GABA-A-mediated anxiety relief. CBD produces anxiety relief without sedation — appropriate for daytime social anxiety, generalized anxiety, and anticipatory anxiety. Valerian produces anxiety relief through sedation — appropriate only at night when drowsiness is acceptable. For daytime anxiety management,CBD Oil is clearly preferable. SeeCBD for Anxiety: The Complete 2026 Guide.
Valerian at standard doses (300–600mg) does not produce meaningful physiological dependence — it is substantially weaker than benzodiazepines and the theoretical GABA-A tolerance concern has not been confirmed in clinical studies at typical supplement doses. However, the GABA-A mechanism in principle carries higher dependence potential than CBD's 5-HT1A mechanism, which shows no dependence signal at any supplement dose. For chronic daily use, CBD (via Sleep Gummies) is a lower-risk long-term choice than high-dose chronic valerian use.
300–600mg standardized valerian root extract (standardized to 0.8% valerenic acid), taken 30–60 minutes before bed. Lower doses are less effective; doses above 600mg increase grogginess risk without improving sleep benefit. Use as needed (not every night) to minimize tolerance potential. The most evidence-supported regimen for valerian: use 2–4 nights per week rather than every night chronically.
At standard doses of both, the direct pharmacokinetic interaction is modest — valerian is a CYP3A4 substrate (mild), and CBD's CYP3A4 inhibition may modestly increase valerian levels. The more clinically relevant concern is thepharmacodynamic additive sedation: both produce CNS calming/sleep-promoting effects (GABA-A for valerian, 5-HT1A + CBN for CBD) that are additive. Standard doses together produce appropriate nighttime sedation. High doses together could produce excess grogginess. The combination is appropriate for deliberate nighttime use; never daytime.
CBD Oil's HPA recalibration is asustained, cumulative mechanism — consistent daily use over 2–4 weeks produces lasting changes in cortisol baseline and HPA rhythm that persist as long as consistent use continues. Valerian's GABA-A sedation is acute — it works on the night you take it and its duration matches its half-life (3–4 hours). For long-term insomnia management,CBD Oil +CBD+CBN Sleep Gummies builds a durable physiological foundation; valerian provides acute sleep onset support that does not build cumulative benefit in the same way.
Valerian root and CBD address sleep from different mechanisms: valerian via GABA-A sedation for acute sleep onset; CBD via 5-HT1A anxiety relief, HPA recalibration, and CBN slow-wave architecture for comprehensive sleep quality. The critical practical distinction: CBD is appropriate anytime; valerian is strictly nighttime.
For most people with chronic insomnia:CBD Oil 15–20mg AM daily as the HPA baseline foundation +CBD+CBN Sleep Gummies every night for architecture, circadian, and HPA sleep support. Valerian 300–450mg can be added for acute sleep onset difficulty on nights when extra help is needed — taken alongsideCBD+CBN Sleep Gummies rather than replacing it. This combination covers GABA-A sedation (valerian) + 5-HT1A anxiolytic (CBD) + CBN architecture + melatonin circadian signal — the most comprehensive natural insomnia protocol available.
PureCraft CBD Oil 1000mg — 15–20mg AM.CBD+CBN Sleep Gummies — nightly 30–45 min before bed. Zero THC, nano-optimized,batch-tested COA.browse all PureCraft CBD products.
Medical Disclaimer | Valerian has additive sedation with alcohol, benzodiazepines, and other sedatives. CBD and valerian are supplements. Chronic insomnia requires physician evaluation. PureCraft CBD products are not intended to diagnose, treat, cure, or prevent any disease. Individual results may vary.
•CBD vs Melatonin: Which Is Better for Sleep Architecture?
•CBD vs GABA Supplements: Anxiety, Sleep, and the Blood-Brain Barrier Question
•CBD vs Glutamine: Gut Health, Immune Recovery, and Muscle Support
•CBD vs Turmeric (Curcumin): Anti-Inflammatory Showdown
•CBD for Sleep: The Ultimate 2026 Guide to Better Rest
•CBD for Insomnia: Does It Actually Put You to Sleep?
•CBD for Anxiety: The Complete 2026 Guide
•CBD for Burnout: Recovery From Chronic Work Stress
•CBD Supplement Stacking Guide: How to Combine CBD With Other Supplements Safely
•CBD and Drug Interactions: The Complete CYP450 Guide
•Shannon et al. (2019): Cannabidiol in Anxiety and Sleep — Permanente Journal → PubMed 30624194
Medical Disclaimer | This article is for educational purposes only. CBD is a supplement, not a medication. Gastrointestinal conditions require phy...
Read More
Medical Disclaimer | This article is for informational purposes only. CBD is a supplement. Clinical burnout or chronic pain requires physician eva...
Read More
Medical Disclaimer | This article addresses CBD for pet owners (human adults) managing caregiver stress — not CBD for pets. Do not give PureCraft ...
Read More